Pages that link to "Q114292208"

The following pages link to Raisa Levin (Q114292208):

Displaying 30 items.

• Nonsteroidal anti-inflammatory drug use and acute myocardial infarction (Q28193035) (← links)
• Agreement of diagnosis and its date for hematologic malignancies and solid tumors between medicare claims and cancer registry data (Q31109905) (← links)
• Measuring concurrent adherence to multiple related medications (Q33866078) (← links)
• False Claims Act prosecution did not deter off-label drug use in the case of neurontin. (Q34238913) (← links)
• The comparative safety of opioids for nonmalignant pain in older adults (Q34625722) (← links)
• Preventive health care measures before and after start of renal replacement therapy (Q34743278) (← links)
• A combined comorbidity score predicted mortality in elderly patients better than existing scores (Q35000472) (← links)
• Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004. (Q35667100) (← links)
• Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age. (Q36947602) (← links)
• Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients (Q37187904) (← links)
• A cohort study of thiazolidinediones and fractures in older adults with diabetes (Q37315675) (← links)
• Nephrologist care and mortality in patients with chronic renal insufficiency (Q43671561) (← links)
• Clozapine use and risk of diabetes mellitus (Q43824843) (← links)
• Dopamine antagonists and the development of breast cancer (Q44241349) (← links)
• Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery (Q44545048) (← links)
• Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes (Q44573010) (← links)
• Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important? (Q44704673) (← links)
• Assessing health state utilities in elderly patients at cardiovascular risk (Q44791016) (← links)
• Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults (Q44851038) (← links)
• The comparative safety of analgesics in older adults with arthritis. (Q45254853) (← links)
• Full prescription coverage versus usual prescription coverage after coronary artery bypass graft surgery: analysis from the post-myocardial infarction free Rx event and economic evaluation (FREEE) randomized trial (Q45894836) (← links)
• Sudden uncontrollable somnolence and medication use in Parkinson disease (Q46640925) (← links)
• Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure (Q50109780) (← links)
• The hidden cost of nonselective nonsteroidal antiinflammatory drugs in older patients (Q50716977) (← links)
• Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis (Q51115204) (← links)
• Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: a propensity score approach. (Q52942231) (← links)
• Full Coverage for Preventive Medications after Myocardial Infarction (Q56872760) (← links)
• Late nephrologist referral and access to renal transplantation (Q74493962) (← links)
• Adherence to Statin Therapy in Elderly Patients After Hospitalization for Coronary Revascularization (Q83637009) (← links)
• Risk Factors for Heart Failure with Preserved or Reduced Ejection Fraction Among Medicare Beneficiaries: Application of Competing Risks Analysis and Gradient Boosted Model (Q96821146) (← links)